NIP Vaccination in Pharmacy expansion improves equitable access to vaccines

20 April 2024


The Pharmaceutical Society of Australia (PSA) welcomes the Albanese Government’s expanded funding for National Immunisation Program Vaccination in Pharmacy (NIPVIP) program in aged care and disability homes from 29 April 2024, actioning one of PSA’s key recommendations in its 2024-25 Federal Budget Submission.


Ahead of World Immunisation Week beginning 24 April 2024, the Minister for Health and Aged Care, Hon Mark Butler MP, has announced that pharmacists will be funded to deliver National Immunisation Program vaccines to some of Australia’s most vulnerable priority population groups.


The Minister has also announced that NIPVIP payments will also be indexed in line with Medicare Benefits Schedule (MBS) indexation from 1 July 2024.


PSA Chief Executive Officer, Adjunct Associate Professor Steve Morris welcomed the move, which PSA – as the only peak body representing all of Australia’s 37,000 pharmacists – has been advocating for, to expand access to funded vaccination services to all pharmacists practising in all locations.


“The expansion of the National Immunisation Program Vaccination in Pharmacy program to include pharmacists practising in residential aged care facilities and in disability care will drastically improve the specialised care pharmacists provide to these patients,” Adj. A/Prof Morris said.


“PSA has been supportive of increased investment in pharmacist vaccination services, supporting the delivery of ‘all vaccines, to all ages, in all locations’ – and therefore, pharmacists welcome this announcement.


“It means pharmacists can deliver more services to the priority groups who are the most heavily reliant on vaccines.


“We are continuing to work with governments across Australia on improvements to the accessibility of vaccination services for all Australians ahead of the winter flu season.”


Adj. A/Prof Morris also welcomed the confirmation of service payment indexation in line with indexation of MBS service payments.


“Lifting remuneration to meet the rising costs of service delivery allows pharmacists to continue delivering critical vaccination clinics,” he said.


“Pharmacists continue to be some of the most accessible vaccination providers, supporting increased vaccination coverage around the country. Adequate pharmacist remuneration is critical to ensuring that these essential services delivered by pharmacists can be delivered sustainably, which ultimately protects and maintains equitable access to vaccination services for all Australians.”


Media contact: Georgia Clarke M: 0480 099 798 E: georgia.clarke@psa.org.au


PSA Faye McMillan Conference Grant launched for its second year

22 March 2024


“Creating spaces of belonging is a critical component for reconciliation in this country. Grant opportunities such as this allow us to hold this space for others to come into.”

Faye McMillan

The Pharmaceutical Society of Australia (PSA) is proud to launch the PSA Faye McMillan Conference Grant for the second consecutive year, with support from Care Pharmaceuticals and Hydralyte.

Aboriginal & Torres Strait Islander pharmacists and interns are invited to apply for the Conference Grant, named after Wiradjuri yinaa (woman) and trailblazing pharmacist Professor Faye McMillan AM FPS.

Professor Faye McMillan is recognised as the first Indigenous Australian to hold a western degree in pharmacy in this country. She is a 2023/24 Harkness Fellow and a founding member of Indigenous Allied Health Australia, and has received numerous accolades for her leadership and contribution to population health, education, equity and the community. These include PSA Pharmacist of the Year (2022), NSW Aboriginal Woman of the Year (2019), and recognition as a Member of the Order of Australia (AM) for her work in Aboriginal and Torres Strait Islander mental health care and tertiary education.

Faye is a strong advocate for improving Indigenous health care across professions and is driven to help promote the participation and inclusion of Aboriginal and Torres Strait Islander people within pharmacy.

PSA Chief Executive Officer Adjunct Associate Professor Steve Morris says that the Grant is just one way that PSA is promoting pathways for First Nations pharmacists.

“While Aboriginal and Torres Strait Islander peoples comprise 3.8% of Australia’s total population, the current proportion of registered pharmacists who identify as Aboriginal and/or Torres Strait Islander people is much lower at just 0.3%.

“As part of our commitment to supporting and helping increase the representation of Aboriginal and Torres Strait Islander people in pharmacy, this grant opportunity looks to supporting the existing pharmacist workforce who identify as Aboriginal and Torres Strait Islander people.

“PSA continues to proudly support Australia’s First Nations pharmacists, and foster new pathways for the First Nations pharmacists of the future,” Adj. A/Prof Morris says.

Care Pharmaceuticals and Hydralyte Marketing Manager Joan Isaac says that support for First Nations pharmacists is key.

“Care Pharmaceuticals and Hydralyte are excited to partner with PSA for the PSA Faye McMillan Conference Grant. Recognising the significance of inclusivity, we acknowledge the ongoing need to increase participation of Aboriginal and Torres Strait Islander people in pharmacy.

“We hope this grant opportunity represents a genuine commitment to support the existing pharmacist workforce who identify as Aboriginal and Torres Strait Islander people.”​

Expressions of interest for the PSA Faye McMillan Conference Grant are open now. Visit https://www.psa24.com.au/grants for more information.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Next generation learning for pharmacy assistants, interns

25 January 2024


The Pharmaceutical Society of Australia (PSA) has partnered with tech company Audirie to modernise pharmacy assistant and intern training programs, integrating tailored learning tools and real-time assessment into pharmacy education.

PSA learners will soon have access to virtual patients as part of their online learning environment, supporting the real-world application of their training material.

PSA Chief Executive Officer Adj A/Prof Steve Morris welcomed the new partnership, reaffirming the organisation’s commitment to enhanced education across the pharmacy sector.

“As a leader in pharmacy education and training, PSA’s excited to provide learners with new and innovative products as part of their education journey.

“We’re proud to be harnessing technology to give our learners the edge, training in real-life scenarios and better preparing them for their careers.

“Our focus remains firmly on providing high quality, practical education to our members and learners, training them to meet the current and future needs of our communities,” he said.

Audirie Chief Executive Officer Michael Alexander said the partnership represented a groundbreaking approach to education in the pharmacy sector.

“As a pharmacist myself, I am excited to collaborate with the Pharmaceutical Society of Australia and bring Audirie to the forefront of pharmacy education,” he said.

“This partnership is a significant step forward in integrating new technologies into the training and assessment processes, ultimately benefitting pharmacy professionals and the industry as a whole.”

About Audirie

Audirie is a leading provider of AI-driven communication solutions, committed to transforming the way individuals learn and grow. With a focus on immersive learning experiences, Audirie harnesses the power of artificial intelligence to deliver innovative and effective training programs across various industries.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au